- Veeva Vault experience- Review of Artwork and Labelling Documents (SmPC, PIL) for submission (Vistalink), language switch of SmPC and PIL- Swiss and German Submissions - eDoc, eCTD, SCP- LCM - CMC Variations in Germany, Austria and Swizterland - Swiss Regulation- eCTD Module 1 & 3- Comparison CCCDS and different approved SmPCs

Laboratory manager:- production of pharmaceutical galenical formulations. Focus on pediatric and veterinary capsules.- implementation of QM system Customer service

Department of Pharmaceutical TechnologyProject: Production of micro and nanoparticles of co-amorphized materials with terapeutic activityPublications: Sulfonic Acid Derivatives in the Production of Stable Co-Amorphous Systems for Solubility Enhancement, J Pharm Sci. 2022 Dec;111(12):3327-3339Conference posters:- 3rd European Conference on Pharmaceutics, Bologna, March 2019, "Comparison of the co-amorphization ability of olanzapine with amino, carboxylic and sulfonic acids"- 4th International Congress of CiiEM 2019, "Co-formability, solubility enhancement and stability of olanzapineco-amorphous systems produced with diferent co-formers";- 11th iMed.ULisboa Postgraduate & i3DU Students Meeting, July 2019, "Increased solubility and stability of co-amorphous systems containing olanzapine and sulfonic acids" Conference oral presentations:- 4th International Congress of CiiEM 2019, June 2019, "Characterization and stability of co-amorphous systems containing olanzapine and sulfonic acids"- 13th PSSRC Annual Meeting at the HHU, September 2019, "Sulfonic acid derivatives as co-formers in olanzapine co-amorphous systems"